NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

The National Institute of Dental and Craniofacial Research (NIDCR), a component of the National Institutes of Health within the U.S. Department of Health and Human Services, offers this funding opportunity to support investigator-initiated observational studies and biomarker validation studies focused on dental, oral, and craniofacial health. The program operates under a cooperative agreement mechanism, indicating substantial involvement from NIH program staff in the conduct and oversight of funded projects. This initiative reflects NIDCR’s broader mission to advance scientific understanding and improve prevention, diagnosis, and treatment of oral and craniofacial diseases through rigorous and reproducible research. The primary purpose of this funding opportunity is to support prospective observational studies or biomarker validation studies that require the collection of new data or biospecimens, or continued analysis of previously collected materials. The scope includes large-scale, resource-intensive studies such as cohort studies, multi-site clinical observations, and studies examining disease progression, treatment outcomes, or risk factors. Biomarker validation studies are also supported, provided they build on previously identified candidate biomarkers and aim to establish clinical or analytical validity in diagnosis, prognosis, or treatment response. Discovery-phase biomarker work and clinical trials are explicitly excluded from eligibility. Funding is provided through cooperative agreements with a maximum of 500000 dollars in direct costs per year, and projects may extend up to five years. While cost sharing is not required, applicants must present detailed and justified budgets. Funds may be used for activities such as data collection, biospecimen analysis, participant recruitment, and statistical analysis, provided they align with NIH policies and the specific objectives of the study. Applicants are expected to demonstrate readiness to initiate studies promptly, including having appropriate infrastructure, personnel, and protocols in place. Eligibility is broad and includes higher education institutions, nonprofit organizations, for-profit entities, and government agencies at various levels, provided they are based in the United States. Foreign organizations and foreign components of U.S. institutions are not eligible. Individuals serving as principal investigators must have the necessary expertise and be affiliated with an eligible organization. All applicants must complete required federal registrations, including SAM, Grants.gov, and eRA Commons, prior to submission. Applications must be submitted electronically through approved NIH systems such as ASSIST or Grants.gov Workspace. Required components include a research strategy, detailed budget, quality management plan, clinical data management plan, and, if applicable, a schedule of events. Applications are evaluated through NIH’s peer review process based on criteria including significance, innovation, rigor, feasibility, investigator expertise, and institutional environment. Additional considerations include protections for human subjects and data management practices. The application timeline follows standard NIH submission cycles with multiple due dates each year, including October 5, February 5, and June 5. The earliest submission date for this opportunity is September 5, 2026, and the funding opportunity remains active through July 6, 2029. Awards are contingent on peer review outcomes, funding availability, and alignment with program priorities. Successful applicants can expect a structured review timeline culminating in potential project start dates several months after submission, depending on the review cycle. Applicants are encouraged to engage with NIDCR program staff prior to submission to ensure alignment with program goals and to strengthen application quality. Contact information for scientific and grants management inquiries is provided, and applicants must adhere strictly to NIH submission guidelines to avoid delays or disqualification. This funding opportunity represents a significant investment in advancing high-quality observational and validation research in oral and craniofacial health.

Ensure strong statistical design and feasibility; demonstrate readiness for participant recruitment and data collection; align biomarker validation with prior evidence; include experienced data coordination and analysis teams